Zobrazeno 1 - 10
of 276
pro vyhledávání: '"R. Keiling"'
Autor:
R. Keiling, Jean-Claude Horiot, R. Rozan, Nicolas J. Daly, Jacques Pigneux, S. Schraub, T. H. Pourquier, X. S. Sun, C. Vrousos, Ph. Maingon
Publikováno v:
Cancer. 69:2505-2509
From 1967 to 1990, 96 previously untreated patients with cervicovaginal cancer associated with a history of vaginal pessary use to control uterovaginal prolapse were referred to eight radiation therapy departments in France. Sixty-eight patients had
Autor:
F, Eichler, R, Keiling
Publikováno v:
Bulletin du cancer. 83(3)
The aim of this study was to compare the survival results at ten years of two groups of respectively 19 and 20 females who had an inflammatory breast cancer, treated with two different neoadjuvant chemotherapy protocols of six days for the first one,
Autor:
Freddy Delgado, R Keiling, Moïse Namer, A. Monnier, M T Closon, Pierre Kerbrat, M A Gil Delgado, Pierre Fumoleau, T. Delozier, E. Garcia-Giralt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(7)
PURPOSE This study investigated the therapeutic effects of single-agent intravenous (IV) weekly Navelbine (vinorelbine or 5'-nor-anhydro-vinblastine; Pierre Fabre Médicament, Boulogne, France), a semisynthetic vinca alkaloid, in women who had receiv
Autor:
P. Fargeot, Pierre Kerbrat, R. Keiling, Henri Roché, M. Van Glabeke, A. Cattan, Pierre Fumoleau, P. Herait, N. Guiochet, Paul Rebattu, Jean-Pierre Armand, M.A. Lentz
Publikováno v:
American journal of clinical oncology. 16(2)
Eighty patients with measurable metastatic colon or renal cancer, melanoma, or sarcoma entered these Phase II studies. A dose of 25 mg/m2/day of Pirarubicin (THP) for 3 consecutive days every 4 weeks for the first patients, and then 20 mg/m2/day for
Autor:
S, Schraub, X S, Sun, P, Maingon, J C, Horiot, N, Daly, R, Keiling, J, Pigneux, H, Pourquier, R, Rozan, C, Vrousos
Publikováno v:
Cancer. 69(10)
From 1967 to 1990, 96 previously untreated patients with cervicovaginal cancer associated with a history of vaginal pessary use to control uterovaginal prolapse were referred to eight radiation therapy departments in France. Sixty-eight patients had
Autor:
Jean-Marc Limacher, B. Duclos, Jean-Pierre Bergerat, D. Leveque, F. Eichler, P. Dufour, R. Keiling, J. Wihlm
Publikováno v:
European Journal of Cancer. 31:S197
Summary We present a phase I study of a 5-fluorouracil (5FU) and folinic acid combination given at high doses in weekly continuous infusions. The aim of the study was to determine the maximal tolerated dose of 5FU and the encountered toxicities. 5FU
Autor:
Raymond Rozan, R. Keiling, Jean-Claude Horiot, Pierre F. Combes, Emmanuel Achille, Henri Pourquier, Jacques Pigneux, Vrousos C, Nicolas J. Daly, S. Schraub
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 11:463-471
From January 1976 to December 1978, 581 previously untreated patients with Stage II carcinoma of the uterine cervix were treated by radiotherapy alone in nine departments of radiotherapy in France. This retrospective analysis was undertaken in an att
Autor:
D. Machover, Morin P, Ana Maria Comaru-Schally, Jean P. Fendler, Pierre Kerbrat, Emmanuel Achille, R. Keiling, Roland Metz, Jacques C. Tronc, Edmond Pappo, Georges Mathé, Jacques Duchier, Bernard Court, Philippe Bouchard, Andrew V. Schally, Gilles Prevot, Marie L. Vovan, Roland Y. Mauvernay, Schwarzenberg L, Jean L. Misset
Publikováno v:
The Prostate. 9:327-342
Various approaches to hormonal treatment of prostate carcinoma are discussed. Eighty-one patients with prostatic carcinoma, eight with stage B, nine with stage C, and 64 with stage D disease, were treated subcutaneously daily for 3 months with the LH
Autor:
Morin P, J.L. Misset, J. C. Tronc, Duchier J, Comaru-Schally Am, E. Pappo, J. P. Fendler, P. Kerbrat, D. Machover, R. Metz, E. Achille, Schally Av, Mathé G, Vovan Ml, G. Prévot, R. Keiling, L. Schwarzenberg
Publikováno v:
Medical Oncology and Tumor Pharmacotherapy. 1:119-122
An oriented phase II trial of D-Trp6-LH-RH was conducted according to Gehan's statistical method on 25 patients suffering from prostatic carcinoma. LH and testosterone serum levels decreased rapidly. Pain disappeared during the third month in 14 out